Page 26 - CJO_SM17_FLIPBOOK
P. 26
C CLINICAL RESEARCH
42. Cheung LK, Eaton A. Age-related macular degeneration. Pharmaco- 51. Holman CAJ, Armstrong BK. Cutaneous malignant melanoma and
therapy 2013;33(8):838-55. indicators of total accumulated exposure to the sun: an analysis
43. Blasiak J, Petrovski G, Veréb Z, et al. Oxidative stress, hypoxia, and separating histogenetic types. J Natl Cancer Inst 1984;73(1):75-82.
autophagy in the neovascular processes of age-related macular 52. Sakamoto Y, Kojima M, Sasaki K. Effectiveness of eyeglasses for pro-
degeneration. Biomed Res Int 2014;2014:768026. tection against ultraviolet rays. Jpn J Opthalmol 1999;43(6):566-7.
44. Barker F, Brainard G. The direct spectral transmittance of the ex- 53. Citek K. Anti-reflective coatings reflect ultraviolet radiation. Optom-
cised human lens as a function of age. US Food and Drug Adminis- etry 2008;79(3):143-8.
tration Report 1991. 54. Guidance document for nonprescription sunglasses; Centre for
45. Gallagher RP, Elwood JM, Rootman J, et al. Risk factors for ocular Devices and Radiological Health, FDA; Department of Health and
melanoma: Western Canada Melanoma Study. J Nat Cancer Inst Human Services: Division of Ophthalmic Devices, 1998:1-14.
1985;74(4):775-8. 55. Rosenthal FS, Bakalian AE, Lou CQ, et al. The effect of sunglasses
46. Lutz J-M, Cree I, Sabroe S, et al. Occupational risks for uveal mela- on ocular exposure to ultraviolet radiation. Am J Public Health
noma results from a case-control study in nine European countries. 1988;78(1):72-4.
Cancer Causes Control 2005;16(4):437-47. 56. Sliney DH. Eye protective techniques for bright light. Ophthalmology
47. Pane AR, Hirst LW. Ultraviolet light exposure as a risk factor for 1983;90(8):937-44.
ocular melanoma in Queensland, Australia. Ophthalm Epidemiol 57. American Cancer Society: Cancer and Sunlight exposure: Available
2000;7(3):159-67. at: http://www.cancer.org/cancer/cancercauses/sunanduvexpo-
48. Seddon JM, Gragoudas ES, Glynn RJ, et al. Host factors, UV radia- sure/sun-and-uv-exposure-, 2016.
tion, and risk of uveal melanoma: A case-control study. Arch Oph- 58. Cancer Council Australia: National Cancer Control Policy; Posi-
thalmol 1990;108(9):1274-80. tion Statement-Sun Exposure and Vitamin D Risks and Benefits:
49. Shah CP, Weis E, Lajous M, et al. Intermittent and chronic ultraviolet Available at:http://wiki.cancer.org.au/policy/Position_statement_-_
light exposure and uveal melanoma: A meta-analysis. Ophthalmol- Risks_and_benefits_of_sun_exposure, 2016.
ogy 2005;112(9):1599-607.
50. Tucker MA, Shields JA, Hartge P, et al. Sunlight exposure as
risk factor for intraocular malignant melanoma. N Engl J Med
1985;313(13):789-92.
Co-Management:
Your patients come first!
Our Co-Management program o ers many advantages:
Over 30 clinics across Canada Experienced surgeons who have
LASIK MD is a platinum member of collectively performed over
Canada’s Best Managed Companies 1 million procedures†
A ordable prices for your patients
More than 15 years of experience starting at $490 per eye*
Direct access to our team: comanagement@lasikmd.com
Book your free consultation at 1-877-793-1515
or at lasikmd.com
†Based on the collective experience of all LASIK MD surgeons in Canada. *Prices are subject to change without prior notice and vary based on prescription strength. Only applicable on a procedure for both eyes.
Other conditions may apply.
26 CANADIAN JOURNAL of OPTOMETRY | REVUE CANADIENNE D’OPTOMÉTRIE VOL. 79 NO. 2
